Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
Year: 2011
Type: article
Source: Annals of Internal Medicine
Authors: Jonas Oldgren, Marco Alings, Harald Darius, Hans-Christoph Diener, John Eikelboom, Michael D. Ezekowitz, Gabriel Kamensky, Paul A. Reilly, Sean Yang, Salim Yusuf, Lars Wallentin, Stuart J. Connolly, on behalf of the RE-LY Investigators
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: atrial fibrillation, dabigatran, warfarin, CHADS2 score, stroke risk, major bleeding, intracranial hemorrhage, vascular death, oral anticoagulants, direct thrombin inhibitors, vitamin K antagonists, RE-LY trial, risk stratification, systemic embolism, mortality risk, congestive heart failure, hypertension, diabetes mellitus
Open Access status: closed
OpenAlex ID: W2113021651
